ESC 365 - Influence of amlodipine on antiplatelet effect of clopidogrel in patients treated with percutaneous coronary intervention: result of the randomized, prospective, two-period, crossover, ACCEL-CCB trial

ESC Premium Access

Influence of amlodipine on antiplatelet effect of clopidogrel in patients treated with percutaneous coronary intervention: result of the randomized, prospective, two-period, crossover, ACCEL-CCB trial

Session: Best Posters 5 - Best Posters in antiplatelet agents in acute coronary syndromes

Topic: Thrombosis and platelets

Speaker: Professor Y. Jeong (Gwangmyeong, KR)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Young-Hoon Jeong

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong (Korea (Republic of))

1 follower

4 more presentations in this session

Discussant: Best Posters in antiplatelet agents in acute coronary syndromes

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: the PCSK9-REACT study

Speaker: Professor E. Navarese (Sassari, IT)

Comparison of Prescription and Bleeding Rates and Clinical Outcomes of Contemporary P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Speaker: Assistant Professor J. Choe (Pusan, KR)

Ticagrelor- and prasugrel-mediated platelet inhibition is not affected by mild therapeutic hypothermia generated in vitro in patients with an acute myocardial infarction

Speaker: Doctor I. Buera Surribas (Barcelona, ES)

Access the full session

Best Posters 5 - Best Posters in antiplatelet agents in acute coronary syndromes

Speakers: Professor Y. Jeong, Professor E. Navarese, Assistant Professor J. Choe, Doctor I. Buera Surribas

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources